β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action

References

Page 1

	Year	Citations
Prevalence of Obesity, Diabetes, and Obesity-Related Health Risk Factors, 2001 Ali H. Mokdad, Earl S. Ford, Barbara A. Bowman, JAMA	2003	5.9K
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome Hiroaki Masuzaki, J. Paterson, Hiroshi Shinyama, Science ObesityMetabolic SyndromeHealth SciencesMetabolic DisorderMedicine	2001	1.8K
Novel Adipose Tissue–Mediated Resistance to Diet-Induced Visceral Obesity in 11β-Hydroxysteroid Dehydrogenase Type 1–Deficient Mice Nicholas M. Morton, Janice M. Paterson, Hiroaki Masuzaki, Diabetes Novel AdiposeMetabolic DisorderGlucocorticoidInsulin SignalingOxidative Stress	2004	497
Metabolic syndrome without obesity: Hepatic overexpression of 11β-hydroxysteroid dehydrogenase type 1 in transgenic mice Janice M. Paterson, Nicholas M. Morton, Catherine Fiévet, Proceedings of the National Academy of Sciences	2004	429
Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2 Yuri Kotelevtsev, Roger Brown, Stewart Fleming, Journal of Clinical Investigation	1999	281
Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Brian R. Walker, A. A. Connacher, R M Lindsay, The Journal of Clinical Endocrinology & Metabolism GlucocorticoidInsulin SignalingMolecular PharmacologyMetabolic SyndromeHepatotoxicity	1995	266
Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Improves Hepatic Insulin Sensitivity in Hyperglycemic Mice Strains Pēteris Alberts, Cecilia Nilsson, Göran Selén, Endocrinology	2003	259
Arylsulfonamidothiazoles as a New Class of Potential Antidiabetic Drugs. Discovery of Potent and Selective Inhibitors of the 11β-Hydroxysteroid Dehydrogenase Type 1 Tjeerd Barf, Jerk Vallgårda, Rikard Emond, Journal of Medicinal Chemistry Pharmaceutical ScienceSelective InhibitorsPharmacotherapyPharmaceutical ChemistryMetabolic Syndrome	2002	211
Diabetes Mellitus: Pathogenesis and Treatment Strategies Jay S. Skyler Journal of Medicinal Chemistry	2004	204
Diabetes Mellitus: Pathogenesis and Treatment Strategies. Jay S. Skyler ChemInform Diabetes ManagementAutoimmune DiseaseDiabetesDiabetes MellitusMedicine	2004	167

Page 1